1. Absolute treatment effects of novel oral antidiabetic drugs on cardiovascular mortality and hospitalization for heart failure: a meta-analysis of digitalized individual patient outcomes. (3rd October 2022) Authors: Wolff, G; Lin, Y; Akbulut, C; Brockmeyer, M; Parco, C; Hoss, A; Sokolowski, A; Westenfeld, R; Kelm, M; Roden, M; Schlesinger, S; Kuss, O Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTION and NCDR risk models outperform GRACE for prediction of in-hospital mortality in acute coronary syndrome – a retrospective analysis from a German Heart Center. (25th November 2020) Authors: Parco, C; Kosejian, L; Quade, J; Bader, S; Lin, Y; Karathanos, A; Krieger, T; Brockmeyer, M; Icks, A; Perings, S; Kelm, M; Schulze, V; Wolff, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis. (14th October 2021) Authors: Lin, Y; Parco, C; Karathanos, A; Krieger, T; Schulze, V; Chernyak, N; Icks, A; Kelm, M; Brockmeyer, M; Wolff, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Iron status, anemia and functional capacity in adults with congenital heart disease: a single center analysis. (25th November 2020) Authors: Karathanos, A; Simon, I; Brockmeyer, M; Lin, Y; Parco, C; Krieger, T; Schulze, V; Hellhammer, K; Kelm, M; Zeus, T; Wolff, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P3624Glycoprotein IIb/IIIa inhibitor therapy in ST-segment elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. (28th August 2018) Authors: Wolff, G; Karathanos, A; Dannenberg, L; Lin, Y; Brockmeyer, M; Heinen, Y; Zeus, T; Kelm, M; Polzin, A; Schulze, V Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Standardized risk management in catheterization procedures for non-ST-segment elevation myocardial infarction: associations with in-hospital clinical outcomes. (25th November 2020) Authors: Troestler, J; Parco, C; Brockmeyer, M; Lin, Y; Krieger, T; Quade, J; Bader, S; Kosejian, L; Karathanos, A; Heinen, Y; Schulze, V; Icks, A; Kelm, M; Wolff, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Uninterrupted direct oral anticoagulants and vitamin K antagonists during ablation for atrial fibrillation: an updated meta-analysis. (25th November 2020) Authors: Brockmeyer, M; Lin, Y; Parco, C; Karathanos, A; Krieger, T; Schulze, V; Heinen, Y; Bejinariu, A; Mueller, P; Makimoto, H; Kelm, M; Wolff, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗